Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 20/20 | 0.67 |
| ▸ | HTR2A | P28223 | 17/20 | 0.67 |
| ▸ | DRD4 | P21917 | 15/20 | 0.67 |
| ▸ | DRD3 | P35462 | 15/20 | 0.67 |
| ▸ | DRD1 | P21728 | 11/20 | 0.67 |
| ▸ | DRD5 | P21918 | 4/20 | 0.67 |
| ▸ | HTR1A | P08908 | 4/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3614573 | 0.98 | DRD2 (0.69) | DRD2HTR2ADRD4DRD3DRD1 | |
| SCHEMBL3622379 | 0.97 | DRD2 (0.64) | DRD2HTR2ADRD4DRD3DRD1 | |
| SCHEMBL3618882 | 0.96 | DRD2 (0.71) | DRD2HTR2ADRD4DRD3DRD1 | |
| SCHEMBL3615796 | 0.96 | DRD2 (0.66) | DRD2HTR2ADRD4DRD3DRD1 | |
| SCHEMBL3611204 | 0.95 | DRD2 (0.67) | DRD2HTR2ADRD4DRD3DRD1 | |
| SCHEMBL4449750 | 0.88 | DRD2 (0.62) | DRD2HTR2ADRD4DRD3DRD1 | |
| SCHEMBL3621854 | 0.82 | DRD2 (0.71) | DRD2HTR2ADRD4DRD3DRD1 | |
| SCHEMBL3617246 | 0.80 | DRD2 (0.68) | DRD2HTR2ADRD4DRD3DRD1 | |
| SCHEMBL3611299 | 0.80 | DRD2 (0.73) | DRD2HTR2ADRD4DRD3DRD1 | |
| SCHEMBL3620522 | 0.79 | DRD2 (0.69) | DRD2HTR2ADRD4DRD3DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2137185-A2 | INDOLIZINES AND AZA-ANALOG DERIVATIVES THEREOF AS CNS ACTIVE COMPOUNDS | Gmeiner, Dr. Peter (DE) | 2009-12-30 | — | — | EP | disclosed |
| WO-2008113559-A2 | INDOLIZINES AND AZA-ANALOG DERIVATIVES THEREOF AS CNS ACTIVE COMPOUNDS | SCHWARZ PHARMA AG (DE) | 2008-09-25 | — | — | WO | disclosed |